First in Class, Potent, and Orally Bioavailable NADPH Oxidase Isoform 4 (Nox4) Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis

出版年份 2010 全文链接

标题

作者

关键词

出版物

Volume 53, Issue 21, Pages 7715-7730

出版商

American Chemical Society (ACS)

发表日期

2010-10-14

DOI

10.1021/jm100773e

Discuss science. Find collaborators. Network.

Join a conversation

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now